Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isabel Lucena

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
The Lancet. Diabetes & Endocrinology|May 10, 2016
Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European populationPär Hallberg, Niclas Eriksson, Luisa Ibañez, et al.
British Journal of Clinical Pharmacology|March 26, 2025
Epigenetic modifications in drug-induced liver injury: A systematic reviewRomina Lorena de Los Santos-Fernández, Antonio Segovia-Zafra, Guillermo Paz-López, et al.
Allergy|July 29, 2023
Patients with naproxen-induced liver injury display T-cell memory responses toward an oxidative (S)-O-desmethyl naproxen metabolite but not the acyl glucuronidePaul Thomson, Nik Fragkas, Laila M Kafu, et al.
British Journal of Pharmacology|June 25, 2025
Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD)Daniel E Di Zeo-Sánchez, Irene Díaz-Alberola, José María Pinazo-Bandera, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2013
Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injuryEugenia Ulzurrun, Camilla Stephens, Esperanza Crespo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2020
Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI RegistryJudith Sanabria-Cabrera, Rocío Sanjuán-Jiménez, Encarnación Clavijo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2022
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI RegistryEinar S Björnsson, Camilla Stephens, Edmond Atallah, et al.
Frontiers in Pharmacology|October 24, 2017
Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in LiverPatricia Rivera, Antoni Pastor, Sergio Arrabal, et al.
Drug Safety|January 13, 2024
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI InitiativeEric B Cohen, Meenal Patwardhan, Ritu Raheja, et al.
Drug Safety|February 17, 2024
Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI InitiativeEric B Cohen, Meenal Patwardhan, Ritu Raheja, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
The Lancet. Diabetes & Endocrinology|May 10, 2016
Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European populationPär Hallberg, Niclas Eriksson, Luisa Ibañez, et al.
British Journal of Clinical Pharmacology|March 26, 2025
Epigenetic modifications in drug-induced liver injury: A systematic reviewRomina Lorena de Los Santos-Fernández, Antonio Segovia-Zafra, Guillermo Paz-López, et al.
Allergy|July 29, 2023
Patients with naproxen-induced liver injury display T-cell memory responses toward an oxidative (S)-O-desmethyl naproxen metabolite but not the acyl glucuronidePaul Thomson, Nik Fragkas, Laila M Kafu, et al.
British Journal of Pharmacology|June 25, 2025
Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD)Daniel E Di Zeo-Sánchez, Irene Díaz-Alberola, José María Pinazo-Bandera, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2013
Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injuryEugenia Ulzurrun, Camilla Stephens, Esperanza Crespo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2020
Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI RegistryJudith Sanabria-Cabrera, Rocío Sanjuán-Jiménez, Encarnación Clavijo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2022
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI RegistryEinar S Björnsson, Camilla Stephens, Edmond Atallah, et al.
Frontiers in Pharmacology|October 24, 2017
Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in LiverPatricia Rivera, Antoni Pastor, Sergio Arrabal, et al.
Drug Safety|January 13, 2024
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI InitiativeEric B Cohen, Meenal Patwardhan, Ritu Raheja, et al.
Drug Safety|February 17, 2024
Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI InitiativeEric B Cohen, Meenal Patwardhan, Ritu Raheja, et al.
Pageof 16